Genetic Tech Ltd.-SP ADRGENE
13F holders, Q4 2025 (December 31)2holders
1new positions
1sold out
$0.11avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Genetic Tech Ltd.-SP ADR (GENE) in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($2K) and BNP Paribas Financial Markets ($0).
- Company
- Genetic Tech Ltd.-SP ADR
- CUSIP
- 37185R406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 15,300 shares bought and 24 shares sold, net +15,276 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 2,650 | $2K |
| BNP Paribas Financial Markets | 0.00% | New | 15,300 | $0 |
"% of holder's portfolio" is GENE's weight in each manager's 13F, not the share of Genetic Tech Ltd.-SP ADR the manager owns.